Topoisomerase I in Human Disease Pathogenesis and Treatments - Wikidata - thesis-toulmin - TriplyDB

Topoisomerase I in Human Disease Pathogenesis and Treatments

Topoisomerase I in Human Disease Pathogenesis and Treatments

http://www.wikidata.org/entity/Q26749484

about

A small molecule screen identifies in vivo modulators of peripheral nerve regeneration in zebrafish.Maintenance of Genome Stability.Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I.Topoisomerase I and Genome Stability: The Good and the Bad.

P2860

Q36390956-52F1C144-8758-4700-A571-48BCC3EA3FBF Q42428926-53183AF5-5091-49FC-9073-9C42E36F7FB3 Q47562008-226131D4-88B4-43AC-9F3A-7D601D3FB002 Q49607733-0CF2720D-3272-4E0A-9C30-85820D6CCB93

P2860

Topoisomerase I in Human Disease Pathogenesis and Treatments

http://www.wikidata.org/entity/Q26749484

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Topoisomerase I in Human Disease Pathogenesis and Treatments

@ast

Topoisomerase I in Human Disease Pathogenesis and Treatments

@en

Topoisomerase I in Human Disease Pathogenesis and Treatments

@nl

type

label

Topoisomerase I in Human Disease Pathogenesis and Treatments

@ast

Topoisomerase I in Human Disease Pathogenesis and Treatments

@en

Topoisomerase I in Human Disease Pathogenesis and Treatments

@nl

prefLabel

Topoisomerase I in Human Disease Pathogenesis and Treatments

@ast

Topoisomerase I in Human Disease Pathogenesis and Treatments

@en

Topoisomerase I in Human Disease Pathogenesis and Treatments

@nl

P1433

Q26749484-76CCC05D-2E0E-4209-BAD2-023EA6BCBE76

P1476

Q26749484-9A2CC831-2F2E-46B2-847A-6E53F73EFC6F

P2093

Q26749484-17646B6F-F61B-493F-B379-914CDDEA7FBA

Q26749484-7938762A-D4B9-4CC2-8B7D-4A6F8D3A934C

P275

Q26749484-AAEDD99F-BE40-4E02-BDC6-EDA107999C2B

P2860

Q26749484-105B67AA-09AA-4CE2-96B7-03AC15384736

Q26749484-18453C33-ABFB-4A7F-9965-483942516839

Q26749484-1B61017D-BA80-41C6-AE14-46EF4FE6EE6D

Q26749484-2172A891-F796-4E77-A847-C7FA6932E1E1

Q26749484-2682F93C-7F30-43AD-843F-F7A150536A0C

Q26749484-28293F8E-3622-4D3E-ACA8-B60FA43B36AD

Q26749484-358C19B7-0F44-465E-B7ED-79CD8518514A

Q26749484-35C84F23-66FA-429C-8207-309842EF9B25

Q26749484-3E0E9C08-F49E-41EF-9115-6DD20A876761

Q26749484-467DA5CB-B833-4986-8244-4D4536E54AD3

P304

Q26749484-6D4822C2-5C6D-486D-8FEB-943A29605D25

P31

Q26749484-9D50FD4A-2A33-4CB5-B46D-71B220EC21FB

Q26749484-E3A8AE98-C026-46A1-9B61-6EBFE721BAEB

P3181

Q26749484-E69202F7-1934-4EFF-B9D8-C8E9F5AA96C7

P356

Q26749484-3BEF9B09-1F8E-4278-A7DC-46A2BB070188

P407

Q26749484-333B7646-AD88-4D2C-891F-1D4E66E0C02F

P433

Q26749484-0DA7708B-C824-49AF-9B9A-7DF9A8D6BC19

P478

Q26749484-33AFC733-3853-4125-8B52-34A487A20AA5

P5008

Q26749484-31E744D1-6CF0-4692-B5B6-E8CD6AE43645

P577

Q26749484-070336EC-B96C-4DFD-BEC3-AFF5D2182932

Q26749484-350AA470-A420-4124-9EB2-8BB9028BED2E

P698

Q26749484-5707697D-50E2-488B-B6D0-A44430C6EB15

P921

Q26749484-0CE92F32-9207-412B-8CE2-FDB2AA8B5FAD

Q26749484-16B8F644-5E52-42D4-9C30-ADA6D3DBE649

Q26749484-32A8E00D-27F8-4E1B-9E3D-82FDC446A82A

Q26749484-53671D5E-44D4-4EE6-B7D8-8C175AEFF441

Q26749484-A2004BFE-1669-4D2E-B7AC-373B697D656A

Q26749484-D994C060-FDA1-46F5-ACA8-6E1101675DAE

Q26749484-EA14B354-F1F5-4DE1-A288-437AB23E1635

P932

Q26749484-431A0129-64F7-49C8-97C7-CA37366AE613

P3181

P356

J.GPB.2016.02.004

P1433

Genomics Proteomics and Bioinformatics

P1476

Topoisomerase I in Human Disease Pathogenesis and Treatments

@en

P2093

Min Li

http://www.w3.org/2001/XMLSchema#string

Yilun Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cellular roles of dna topoisomerases: a molecular perspective

The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK

Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy

Targeted disruption of the mouse topoisomerase I gene by camptothecin selection

Topoisomerase levels determine chemotherapy responsein vitroandin vivo

Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes

The phosphoCTD-interacting domain of Topoisomerase I

Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription

P304

166-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

679517

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.GPB.2016.02.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27181710

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

nuclear protein

transport protein

mechanism of action

P932

4936607

http://www.w3.org/2001/XMLSchema#string